Purpose: To determine if modem transmission of blood glucose data by patients with gestational diabetes could provide faster communication of results, increased clinic work-flow efficiency, and equivalent accuracy. Participant and health care provider satisfaction with the technique was also assessed.
Data sources: Participants were randomized to the modem group, which used the Acculink Modem to report blood glucose data, or to the control group, which used the telephone to report the data. Telephone consultation time, clinic visit time, and accuracy of data were measured. Participants and health care providers completed satisfaction questionnaires.
Conclusions: No significant differences in telephone consultation time, clinic work-flow efficiency, or accuracy were found between the groups. However, both the modem group and clinic staff were highly satisfied with telemedicine transmission of blood glucose data.
Implications for practice: Telemedicine is a convenient method for monitoring patients with gestational diabetes mellitus. As a result of this study, modem transmission was instituted in our clinic for insulin pump patients interested in using modem technology.